Steve Schonfeld’s Amgen AMGN Stock Holding History

Steve Schonfeld’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-55,000	Closed	-$17.7M	–	1975
2024 Q3	$17.7M	Buy	+55,000	New	+$18M	0.12%	168

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Steve Schonfeld's AMGN Position: Q1 2026 in Review

Steve Schonfeld sold out of Amgen (AMGN) in Q1 2026, closing a stake of 36,625 shares — an estimated $13.1M sold.

Steve Schonfeld first reported a position in AMGN in Q3 2016 and held it in 26 quarters. The position peaked at $32.1M in Q2 2022. 3,142 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

Steve Schonfeld reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
Steve Schonfeld sold 36,625 Amgen shares in Q1 2026, an estimated $13.1M.
Steve Schonfeld first reported a position in Amgen in Q3 2016 and held it in 26 quarters.
Steve Schonfeld's Amgen position peaked at $32.1M in Q2 2022.
3,142 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q1 2026, filed 15 May 2026.